As a result, they become more vulnerable to oxidative damage, eventually resulting in the death of -cells and it is clearly showing that there is a clear connection between oxidative stress, mitochondrial dysfunction, and T2D (Rocha et al., 2020)
2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S
Learn more about C12-15 Alkyl Benzoate Cyclohexasiloxane is a type of silicone more commonly known as D6
They can lead to weight loss in several ways, including: Slowing stomach emptying: Slower digestion means that your body releases less glucose (sugar) from your food into your bloodstream
In clinical trials, participants using Zepbound achieved an average weight loss of approximately 20.2% over 72 weeks, while those on Wegovy experienced about a 13.7% reduction
You also need to consider that you may need to take a GLP-1 for a long time, or maybe forever